mast
 

Course Description

Introduction

Human and Financial Costs

Risk Factors

Methods of Surveilance

Strategies to Prevent Infection

Summary of Infection-prevention Practices

Strategies to Prevent CRBSI

Success Stories

Implementing CRBSI Prevention Strategies: Interview with Experts

References

Disclaimer

 

Human and financial costs           

It has been estimated that, in the United States, 80 000 CVC-associated bloodstream infections and 28 000 deaths occur annually among patients in intensive care units (ICUs). The average rate of CVC-associated bloodstream infections is 5.3 per 1000 catheter days.3 (Table 1)The attributable cost of care for a patient with a CABSI is estimated to be between $34 508 and $56 000.4,5 The annual cost of care for all patients with CABSIs ranges from $296 million to $2.3 billion.6,7 It is estimated that the annual number of CABSIs in hospitals in the U.S. is 250 000, with mortality at 12%–25%.8     

CABSIs increase the length of hospitalization and can result in sepsis, septic shock, multi-organ failure, endocarditis, thrombophlebitis, and death.9 Other complications include local and systemic infection, lung abscess, brain abscess, osteomyelitis, and endophthalmitis.2
(Table 1 – NNIS Data)

table_2

Next page